---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-007429"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2026-02-19T23:59:59+00:00"
generated_at: "2026-05-16T01:54:00.445685+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical CEO to speak at SAGES NBT Innovation Weekend panel on endovascular robotics

## Summary
- CEO Harel Gadot will be a featured panelist at The Surgical Disruptive Technology Summit (Feb 19-21, 2026 in Houston, TX).
- Panel titled 'Endovascular Therapeutics: AI and Robotics' to highlight the LIBERTY Endovascular Robotic System.
- LIBERTY is FDA cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
- Limited market release commenced in late 2025; full market release planned at SIR conference in April 2026.

## SEC filing metadata
- accession: 0001493152-26-007429
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2026-02-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315226007429/0001493152-26-007429-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315226007429/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-007429
- JSON: https://secwatch.observer/filing/0001493152-26-007429.json
- Plain text: https://secwatch.observer/filing/0001493152-26-007429.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.